Deep Time
Powdered minerals were ground into cosmetics across the ancient Mediterranean. No ancient culture knew of mesothelioma or fiber pathogenicity; disease recognition is a twentieth-century instrument. The deep history explains why talc and asbestos appear in the same ground. The U.S. Geological Survey records asbestos known in Baltimore and Cecil Counties, Maryland as early as 1837, and states that the region's amphibole deposits are almost all closely associated with talc (USGS Bulletin 1082-K, p. 803).
The Geology
Talc is a hydrous magnesium silicate formed in metamorphosed ultramafic rock, the same environments that host asbestiform amphiboles. Rohl 1974 (PMID 4470924) published the detection-method problem; Rohl, Langer and Selikoff 1976 (PMID 1011287) found 10 of 20 consumer talcum products contained detectable tremolite and anthophyllite. IARC Monographs Volume 136 (July 2024) classifies talc as Group 2A.
The human evidence: peer-reviewed case series document mesothelioma following cosmetic-talc exposure — Gordon 2014 (PMID 25185462), Moline 2020 (33 cases, PMID 31609780), Emory 2020 (75 patients, PMID 32175619), growing to 166 reported cases by 2023 (PMC9847157). Dr. Jacqueline Moline testified before Congress in December 2019; the company's CEO declined to appear.
The Documented Record
1958 Battelle analysis of Italian talc reporting fibrous tremolite; 1969 internal memorandum acknowledging tremolite asbestos; 1972 FDA memorandum recording no disagreement about the potential safety hazard; 1971-76 trade-association push for a weaker method and the term nondetected (PMID 31095409); the 1977 Lancet commentary later retracted.
The science had authors: company medical director G.Y. Hildick-Smith's 1976 review The biology of talc (PMID 793610); a published appellate opinion's recitation that company funding of a 2008 review article was concealed; and The Lancet's formal retraction of the 1977 commentary on March 25, 2026 (PMID 41903566).
Who They Sold To
The 1992 Baby Powder Category Activity memo records 52.0% African American and 37.6% Hispanic usage and names ethnic opportunities to grow the franchise (UCSF IDL Exhibit 184, Bates JNJ 000021090-92). A later undated deck names Multicultural AA and Hispanic as a target segment (CHRG-116hhrg48687 pp. 306-319). Motive is labeled inference; the dates are the dates.
The epidemiology in both directions: AACES reports adjusted OR 1.44 (95% CI 1.11-1.86) for genital powder use among African American women (PMID 27197282); the OCWAA consortium estimates a 36.0% versus 13.8% population-attributable risk for a group of modifiable exposures including body powder (PMID 33252629), while finding odds ratios similar across race (PMID 34155063). The 2020 JAMA pooled cohort analysis found no significant overall association (HR 1.08, 95% CI 0.99-1.17; PMID 31910280); a 2024 Sister Study re-analysis reported HR 1.40 under one bias-correction scenario (PMID 38748950). The tension is reported, not resolved.
Still on Shelves
FDA surveys: 2009-2010 zero positives in 61 result rows; FY2019 nine of fifty-two samples positive including Johnson's Baby Powder Lot #22318RB (recalled); FY2021-2023 zero of fifty each year; no published 2024-2025 results. The MoCRA standardized testing rule was proposed December 2024 (FR 2024-30544) and withdrawn November 2025 (FR 2025-21407). In 2024, FDA routine sampling found asbestos in Dynacare Baby Powder: 62 cases recalled September 19, expanded October 28 to 1,082 cases across 13 lots in 35 states and on Amazon.
The alternative was always on the shelf: internal 1977 consumer research found mothers preferred cornstarch (hedged pending the Bates-stamped study); a company-commissioned 2008 Research International survey found women preferred cornstarch-based powder (CHRG-116hhrg38735); the talc exit came in 2020 (U.S./Canada) and 2023 (global) — forty-three years after the preference signal.
The Courts
Ingham v. Johnson & Johnson, 608 S.W.3d 663 (Mo. Ct. App. 2020), cert. denied 141 S. Ct. 2716: $550M compensatory plus $4.14B punitive, reduced award $2,115,909,091 by the opinion's own arithmetic. In re LTL Management, 64 F.4th 84 (3d Cir. 2023) dismissed the Texas Two-Step bankruptcy for lack of financial distress. Salcedo v. Cyprus Amax Minerals, 2026 IL App (1st) 242199, affirmed a talc-mesothelioma judgment. R.T. Vanderbilt Co. v. OSHRC, 728 F.2d 815 (6th Cir. 1984), is included for balance.
The endgame: in June 2024, J&J agreed to pay $700 million to a coalition of 42 states and the District of Columbia to resolve consumer-protection claims over its talc marketing, and covenanted not to resume selling talc powder products in the United States (N.Y. consent judgment, no admission of wrongdoing). Kenvue's SEC filings record that J&J retained U.S./Canada talc liabilities in the consumer-health spinoff. The bankruptcy route ran its full course: LTL II (filed April 2023, dismissed July 2023, affirmed June 2024) and Red River Talc LLC, No. 4:24-bk-90505 (Bankr. S.D. Tex., dismissed March 31, 2025; no appeal). On July 27, 2026, an 8-K disclosed a proposed comprehensive ovarian-talc resolution: a $5.5 billion commitment conditioned on at least 95% claim participation. On July 22, 2026, the MDL court granted a show-cause motion concerning specific-causation evidence.
The Ledger, Method and Corrections
Claims are separated into Proven (dated primary record), Alleged (always attributed), and Disputed (open literature). The public corrections log records 1957-to-1958, $2.24B-to-$2,115,909,091, the 1992 Revitalization Plan conflation, and the 686-of-1,032 statistic. Downloads: CSV and JSON-LD ledger, CC BY 4.0.